Bridging Policy, Market Access and Commercial Growth
Helping healthcare innovators navigate funding, reimbursement, market access and commercialization opportunities across China and Asia-Pacific.
ACCESSBRIDGE helps healthcare companies transform complex healthcare systems into clear strategic roadmaps, actionable plans, and sustainable growth opportunities.
HEALTHCARE STRATEGY ADVISORY
Turning Healthcare Complexity into Strategic Growth
Healthcare companies often face challenges such as:
Why was our reimbursement application rejected?
Why has our funding application been under review for years while still no result?
Why did we secure reimbursement but fail to protect price?
How do we develop a successful market entry strategy?
How do we align with healthcare policy priorities?
How do we accelerate adoption and commercial growth?
ACCESSBRIDGE helps clients answer these questions through structured analysis, strategic planning, and practical execution roadmaps.
Secure Funding & Reimbursement
Build Market Access-Led Growth Strategies
Shape the Policy Environment
Develop funding and reimbursement strategies that improve success probability, protect pricing, reduce risks, and maximize long-term commercial value.
Develop market entry and commercialization strategies by integrating healthcare policy, reimbursement environments, stakeholder incentives, treatment pathways, and healthcare system priorities.
Design policy engagement, evidence generation, partnership, and stakeholder programs that support sustainable adoption and long-term market development.
THE DIFFERENCE
WHY ACCESSBRIDGE
Strategy Before Execution
Enable Existing Teams
Bridge Policy and Commercial Reality
Define objectives, opportunities and risks before execution begins.
Strengthen capabilities without adding headcount.
Align healthcare system priorities with sustainable commercial growth.
Real-World Experience
20 years across WHO, pharma, medtech, vision care and APAC healthcare systems.
FOUNDER
Meet the Founder
Ziyan Wang
Founder & Principal Consultant
Ziyan Wang is a healthcare market access, commercialization, and policy strategist with nearly 20 years of experience across pharmaceuticals, medical devices, diagnostics, and healthcare innovation.
Her experience spans leadership roles at Johnson & Johnson, Eli Lilly, Bristol Myers Squibb, Bracco, and LivaNova, supporting reimbursement, market access, policy, pricing, and commercialization initiatives across China and Asia-Pacific.
Prior to industry, she worked with the World Health Organization (WHO) and the London School of Economics (LSE Health), building a strong foundation in health policy, healthcare financing, and healthcare system analysis.
She is also co-author of Towards A Healthy China: The Institutional Logic and Strategic Pathways to a Pharmaceutical Powerhouse.
CONTACT
Let's Discuss Your Next Growth Challenge
Whether you are pursuing reimbursement, market entry, commercialization, policy engagement, distributor strategy, or growth opportunities, ACCESSBRIDGE can help you build a clearer path forward.
Singapore